| 2010 |
Title |
Source |
![]() |
Fragments: past, present and future Mark Whittaker et al |
Drug Discovery Today:Technologies 2010, 7 (3): e163-e71 |
![]() |
Using electrophysiology and in silico three-dimensional modeling to reduce human Ether-à-go-go in a histamine H3 receptor antagonist program related gene K+ channel |
Assay and Drug Development Technologies 2010, 8(6):781-9 |
![]() |
Discovery of substituted benzyl tetrazoles as histamine H3 receptor antagonists Adam Davenport et al |
Bioorganic & Medicinal Chemistry Letters 2010, 20(17):5165-69 |
![]() |
Fragment-based discovery and optimization of BACE1 inhibitors James Madden et al |
Bioorganic & Medicinal Chemistry Letters 2010, 20(17):5329-33 |
![]() |
Stephen East et al |
Bioorganic & Medicinal Chemistry Letters 2010, 20(16):4901-5 |
![]() |
Keeping the rhythm: hERG and beyond in cardiovascular safety pharmacology Clemens Moeller |
Expert Review of Clinical Pharmacology 2010, 3 (3) 321-29 |
![]() |
Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae W Alderton et al |
Xenobiotica 2010, 40(8):547-57 |
![]() |
Jörg Bentzien et al |
Journal of Chemical Information and Modeling 2010, 50(2):274–97 |
|
A Profiling Platform for the Characterization of Transglutaminase 2 (TG2) Inhibitors Sabine Schärtl et al |
Journal of Biomolecular Screening 2010, 15(5):478-87 | |
|
Impact of new technologies for cellular screening along the drug value chain Clemens Moeller et al |
Drug Discovery Today 2010, 15(9-10):384-90 | |
![]() |
Stephen East et al |
Expert Opinion in Therapeutic Patents 2010, 20(3):441-5 |
![]() |
Myron A Smith et al |
Journal of Biological Chemistry 2010, 285(17):12873-81 |
![]() |
High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligand Robert Cheng et al |
Protein Science 2010, 19(1):168-73 |